ArticleHemaSphere2026
Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers.
Abstract readLetter
In one paragraph
Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors.
Allison M BockDepartment of Internal Medicine, Division of Hematology and Hematologic Malignancies Huntsman Cancer Institute at the University of Utah Salt Lake City Utah USA.ORCID https://orcid.org/0000-0002-3174-8877
Peirong HaoDepartment of Internal Medicine, Division of Epidemiology University of Utah Salt Lake City Utah USA.
Yizhe XuDepartment of Internal Medicine, Division of Epidemiology University of Utah Salt Lake City Utah USA.
Efrat LuttwakDepartment of Medicine, Division of Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York City New York USA.ORCID https://orcid.org/0000-0003-0212-2135
Swetha Kambhampati ThiruvengadamDepartment of Hematology and Hematopoietic Cell Transplantation, Division of Lymphoma City of Hope National Medical Center Duarte California USA.
Kanithra SekaranDepartment of Medicine, Division of Hemtology and Oncology Northwestern University Evanston Illinois USA.
Dahlia SanoDepartment of Medicine, Division of Hematology and Oncology University of Michigan Ann Arbor Michigan USA.
John VaughnDepartment of Medicine, Division of Hematology and Medical Oncology New York University New York New York USA.
John SharpDepartment of Medicine, Division of Hematology, The James Comprehensive Cancer Center The Ohio State University Columbus Ohio USA.ORCID https://orcid.org/0000-0001-5765-8549
Ajay MajorDepartment of Medicine, Division of Hematology University of Colorado Cancer Center Aurora Colorado USA.
Vrutti PatelDepartment of Medicine, Division of Hematology and Oncology University of Pennsylvania Philadelphia Pennsylvania USA.
Gordon SmilnakDepartment of Medicine, Division of Hematology and Oncology University of Virginia Charlottesville Virginia USA.
Nicole AraujoDepartment of Medicine, Division of Lymphoma Hackensack University Medical Center Hackensack New Jersey USA.
Ritwick MynamDepartment of Medicine, Division of Hematology, Medical Oncology and Palliative Care University of Wisconsin Carbone Cancer Center Madison Wisconsin USA.
Daniel ReefDepartment of Medicine, Division of Hematology University of North Carolina Chapel Hill North Carolina USA.
Marisa PalmeriDepartment of Medicine, Division of Hematology Rutgers Cancer Institute New Brunswick New Jersey USA.
Drew GerberDepartment of Medicine, Division of Hematology/Oncology Columbia University New York New York USA.
Anuja AbhyankarDepartment of Medicine, Division of Hematology and Oncology Roswell Park Buffalo New York USA.
Grace BaekDepartment of Medicine, Divison of Hematology and Oncology Fred Hutchinson Cancer Center Seattle Washington USA.
Ayo FaladeDepartment of Medicine, Division of Hematology Mayo Clinic Rochester Minnesota USA.
Madiha IqbalDepartment of Medicine, Division of Hematology Mayo Clinic Jacksonville Florida USA.
Boyu HuDepartment of Internal Medicine, Division of Hematology and Hematologic Malignancies Huntsman Cancer Institute at the University of Utah Salt Lake City Utah USA.
Praveen Ramakrishnan GeethakumariDepartment of Medicine, Division of Hematology and Oncology Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center Dallas Texas USA.
Urshila DuraniDepartment of Medicine, Division of Hematology Mayo Clinic Rochester Minnesota USA.
Mengyang DiDepartment of Medicine, Divison of Hematology and Oncology Fred Hutchinson Cancer Center Seattle Washington USA.ORCID https://orcid.org/0000-0001-6165-2617
Alex NiuDepartment of Medicine, Division of Hematology and Oncology Roswell Park Buffalo New York USA.
Hua-Jay J CherngDepartment of Medicine, Division of Hematology/Oncology Columbia University New York New York USA.
Joanna M RhodesDepartment of Medicine, Division of Hematology Rutgers Cancer Institute New Brunswick New Jersey USA.
Natalie GroverDepartment of Medicine, Division of Hematology University of North Carolina Chapel Hill North Carolina USA.
Priyanka PophaliDepartment of Medicine, Division of Hematology, Medical Oncology and Palliative Care University of Wisconsin Carbone Cancer Center Madison Wisconsin USA.
Tatyana FeldmanDepartment of Medicine, Division of Lymphoma Hackensack University Medical Center Hackensack New Jersey USA.
Krithika ShanmugasundaramDepartment of Medicine, Division of Hematology and Oncology University of Virginia Charlottesville Virginia USA.
Jakub SvobodaDepartment of Medicine, Division of Hematology and Oncology University of Pennsylvania Philadelphia Pennsylvania USA.
Timothy VoorheesDepartment of Medicine, Division of Hematology, The James Comprehensive Cancer Center The Ohio State University Columbus Ohio USA.
Catherine DiefenbachDepartment of Medicine, Division of Hematology and Medical Oncology New York University New York New York USA.
Yasmin KarimiDepartment of Medicine, Division of Hematology and Oncology University of Michigan Ann Arbor Michigan USA.
Reem KarmaliDepartment of Medicine, Division of Hemtology and Oncology Northwestern University Evanston Illinois USA.
Alex F HerreraDepartment of Hematology and Hematopoietic Cell Transplantation, Division of Lymphoma City of Hope National Medical Center Duarte California USA.
Pallawi TorkaDepartment of Medicine, Division of Hematologic Malignancies Memorial Sloan Kettering Cancer Center New York City New York USA.
Narendranath EpperlaDepartment of Internal Medicine, Division of Hematology and Hematologic Malignancies Huntsman Cancer Institute at the University of Utah Salt Lake City Utah USA.ORCID https://orcid.org/0000-0002-8216-3457
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.